These data were generated from an analysis of the Phase III, randomized, controlled clinical trial that investigated the treatment effect of Vectibix in patients with metastatic colorectal cancer
WX-671 was administered in different doses to patients for 15 days before surgery. It was found to be safe and well tolerated at all dose levels tested. The
This recommendation is based on the safety analyses of data from thoracic subjects who have been treated at the 9mg dosage level and overall evaluation of safety of
The European Medicines Agency’s (EMEA) orphan medicinal product designation is designed to encourage sponsors in developing drugs, which may provide significant benefit to patients suffering from rare diseases
Compared to placebo, patients treated with APD125 experienced statistically significant improvements in measurements of sleep maintenance, or the ability to maintain sleep during the night after falling asleep.
Patient enrollment in this Phase I/IIa trial required stepwise enrollment by escalating dose cohort, with a pause for safety evaluation required after the last patient in the previous
A preliminary analysis of the study results demonstrated that it is safe and well-tolerated at the doses examined, and produced a statistically significant reduction in plasma triglyceride levels,
This pivotal trial will assess progression-free survival as the primary endpoint and overall survival as a secondary endpoint in patients with metastatic sarcomas following a favorable response to
Providing an update on CUDC-101 and other preclinical drug candidates under its targeted cancer drug development platform, the company said CUDC-101 is its lead multi-target inhibitor drug candidate
The approved label includes both complicated skin and skin structure infections caused by certain gram positive infections, at an approved dose of 4 mg/kg, and bloodstream infections, including
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.